new
variant
porcin
epidem
diarrhea
viru
pedv
emerg
swine
diseas
kill
consider
number
neonat
piglet
north
america
asia
recent
year
gener
immunogen
mimick
complex
spike
protein
fold
proper
posttransl
modif
mount
robust
immun
respons
highli
virul
pedv
two
baculovirus
display
fulllength
protein
sbac
protein
virul
taiwan
genotyp
pedv
pintung
pedvpt
strain
construct
intramuscular
immun
mice
piglet
sbac
demonstr
significantli
higher
level
system
antipedv
sspecif
igg
compar
control
group
result
also
show
piglet
sbac
group
elicit
superior
pedvspecif
neutral
antibodi
control
group
highli
virul
pedvpt
strain
challeng
experi
show
piglet
immun
sbac
show
milder
clinic
symptom
significantli
less
fecal
viral
shed
compar
nonimmun
control
piglet
importantli
piglet
immun
sbac
exhibit
mild
clinic
sign
delay
minim
viral
shed
result
demonstr
sbac
could
serv
safe
easi
manipul
effect
vaccin
candid
pedv
infect
pedv
countri
therefor
develop
taiwan
pedvbas
vaccin
would
help
control
reduc
diseas
burden
porcin
epidem
diarrhea
viru
belong
famili
coronavirida
subfamili
coronavirina
genu
alphacoronaviru
viru
singl
kb
posit
strain
rna
genom
encod
seven
open
read
frame
orf
gene
encod
replicas
gene
encod
accessori
protein
gene
encod
four
structur
protein
name
spike
envelop
e
nucleocapsid
n
membran
protein
among
structur
protein
protein
respons
virushost
recognit
viru
intern
neutral
antibodi
induct
principl
antigen
determin
natur
assembl
protein
form
homotrimer
structur
sever
predict
glycosyl
site
glycoprotein
divid
domain
specif
cleavag
site
domain
contribut
receptor
recognit
enteropathogen
immunogen
contain
domin
neutral
epitop
thu
main
target
vaccin
develop
link
domain
anchor
viral
membran
trigger
membran
fusion
sever
neutral
epitop
protein
pedv
describ
includ
epitop
coe
epitop
antigen
epitop
motif
recogn
monoclon
antibodi
c
termin
end
protein
domain
therefor
protein
consid
major
target
pedv
vaccin
develop
baculoviru
express
system
long
util
differ
biolog
purpos
instanc
recombin
protein
product
vaccin
manufactur
gene
therapi
among
variou
strain
autographa
californica
multipl
nucleopolyhedroviru
acmnpv
popular
strain
laboratori
applic
high
protein
product
larg
capac
flexibl
accommod
long
insert
high
biosafeti
vertebr
delic
posttransl
modif
advantag
baculoviru
express
system
furthermor
vaccin
candid
viral
particl
baculoviru
abl
evok
robust
innat
immun
respons
regul
cytokin
well
serv
adjuv
role
promot
b
cell
cell
activ
improv
humor
immun
respons
baculoviru
stabl
dna
viru
store
c
year
without
signific
chang
viru
titer
also
viru
easi
propag
high
titer
around
recent
baculovirusexpress
viral
surfac
protein
becom
novel
strategi
recreat
complex
protein
fold
function
properti
given
baculoviru
abl
mount
robust
immun
respons
baculoviru
display
heterolog
protein
surfac
could
novel
tool
develop
new
gener
vaccin
context
sever
immunogen
gener
use
baculoviru
display
strategi
proven
abl
induc
strong
humor
immun
protect
infecti
diseas
present
studi
take
advantag
recombin
baculoviru
display
system
pedv
fulllength
protein
pedv
protein
name
sbac
construct
display
baculoviru
immunogen
sbac
compar
evalu
mice
pig
intramuscular
im
inject
without
cooper
adjuv
protect
efficaci
baculoviru
display
vaccin
highli
virul
pedvpt
strain
also
evalu
porcin
epidem
diarrhea
ped
highli
contagi
swine
diseas
character
acut
wateri
diarrhea
vomit
piglet
ped
first
identifi
europ
subsequ
becam
endem
diseas
sporad
outbreak
asia
europ
sinc
late
highli
virul
porcin
epidem
diarrhea
viru
pedv
emerg
attack
neonat
piglet
china
outbreak
highli
virul
ped
report
north
america
east
asia
includ
taiwan
result
dramat
econom
loss
swine
industri
lot
effort
made
develop
vaccin
control
epidem
ped
howev
effect
commerci
vaccin
avail
control
ped
worldwid
valid
safe
costeffect
vaccin
control
pedv
therefor
urgent
need
addit
phylogen
analysi
new
taiwan
pedv
strain
show
high
sequenc
ident
nucleotid
sequenc
gene
deriv
taiwan
pedvpt
strain
genbank
access
codon
optim
insect
cell
synthes
protech
protech
taipei
taiwan
pedv
full
length
spike
gene
clone
plasmid
novagen
merck
bioscienc
darmstadt
germani
bring
ptriex
respect
plasmid
contain
tripartit
cmv
promot
conveni
express
insect
mammalian
bacteri
cell
fulllength
protein
sequenc
driven
triex
promot
plasmid
ptriex
respect
figur
mcherri
gene
driven
binari
promot
emit
report
fluoresc
mammalian
cell
plasmid
construct
accord
instruct
manual
infus
hd
clone
kit
clontech
laboratori
inc
fremont
ca
usa
figur
organ
express
cassett
construct
map
plasmid
ptriex
gener
membraneanchor
recombin
baculoviru
sbac
fulllength
spike
gene
driven
triex
promot
follow
signal
protein
ptriex
contain
codon
optim
fulllength
gene
deriv
taiwan
pedvpt
strain
origin
pedv
transmembran
domain
tm
pedv
cytoplasm
domain
ctd
membran
anchor
codon
optim
gene
associ
transmembran
domain
tmb
cytoplasm
domain
ctdb
membran
anchor
construct
also
insert
mcherri
fluoresc
protein
gene
driven
promot
report
plasmid
ptriex
cotransfect
miru
madison
wi
usa
dna
cell
cellfectin
life
technolog
carlsbad
ca
usa
gener
recombin
baculovirus
sbac
express
mcherri
gene
product
use
trace
proper
viral
infect
protein
express
sbac
viru
clone
high
titer
select
use
subsequ
recombin
baculoviru
product
infect
cell
lysat
subject
gradient
sodium
dodecyl
sulfat
sd
polyacrylamid
electrophoresi
page
gel
hr
gradient
gel
solut
tool
taipei
taiwan
electrophoresi
protein
transfer
pvdf
membran
protein
signal
detect
use
mous
monoclon
antibodi
dilut
enogen
new
york
ny
usa
goat
antimous
igg
conjug
hrp
dilut
invitrogen
carlsbad
ca
usa
use
secondari
antibodi
signal
detect
protein
band
detect
use
western
ecl
blot
substrat
biorad
hercul
ca
usa
use
classic
blue
autoradiographi
film
bx
life
scienc
valley
park
mo
usa
supernat
collect
sbacinocul
cell
cell
debri
coars
remov
centrifug
rpm
min
supernat
collect
subject
onto
ww
sucros
cushion
tube
beckman
brea
ca
usa
centrifug
rpm
min
c
obtain
viral
pellet
discard
supernat
viral
pellet
resuspend
ml
pb
subject
ww
sucros
gradient
rpm
h
viral
particl
collect
wash
pb
remov
sucros
purifi
viral
particl
fix
label
antihi
immunogold
visual
electron
microscopi
em
neg
stain
describ
previou
studi
briefli
aliquot
viru
particl
prepar
load
onto
carbonco
grid
let
stand
min
grid
stain
phosphotungst
acid
pta
min
excess
pta
drain
complet
dri
grid
examin
directli
em
immunogold
label
viru
particl
load
onto
collodionco
em
grid
min
remov
excess
viral
particl
gentli
blot
filter
paper
edg
grid
antihi
tag
antibodi
invitrogen
ad
onto
grid
incub
h
room
temperatur
grid
underw
wash
six
time
pb
room
temperatur
incub
nm
goldconjug
antimous
igg
h
six
wash
pb
grid
stain
pta
min
drain
dri
examin
em
twelv
balbc
mice
randomli
divid
three
group
control
sbac
group
mice
immun
intramuscularli
thigh
either
sbac
dosag
per
shot
mice
control
group
inject
cell
cultur
medium
inject
perform
two
time
interv
blood
collect
day
preprim
week
prime
week
postboost
evalu
chang
pedvspecif
igg
fifteen
fiveweek
old
larg
white
duroc
crossbr
pedvseroneg
fecal
pedv
shed
neg
pig
screen
experiment
applic
piglet
label
ear
tag
stochast
separ
three
group
includ
control
group
im
inject
group
sbac
im
inject
group
hous
three
separ
room
group
pig
intramuscularli
inject
ml
control
medium
ml
ml
sbac
side
thigh
two
time
twoweek
interv
day
pig
oral
challeng
ml
challeng
clinic
sign
score
rectal
swab
collect
everi
day
monitor
viral
shed
mucos
iga
blood
collect
everi
two
week
order
evalu
pedv
proteinspecif
plasma
igg
anim
experiment
procedur
perform
anim
review
approv
institut
anim
care
use
committe
nation
taiwan
univers
taipei
taiwan
clinic
sign
pig
observ
record
everi
day
condit
diarrhea
associ
pedv
challeng
score
four
level
normal
stool
loos
consist
stool
semifluid
consist
stool
wateri
diarrhea
addit
pig
group
weigh
everi
two
week
purifi
recombin
protein
express
hek
cell
previous
describ
coat
ninetysix
well
nunc
maxisoap
plate
thermo
fisher
scientif
waltham
usa
concentr
dilut
coat
buffer
kpl
seracar
milford
usa
c
h
scoat
plate
firstli
wash
six
time
wash
buffer
kpl
seracar
block
block
buffer
kpl
seracar
room
temperatur
rt
h
centrifug
rpm
min
remov
blood
cell
blood
sampl
mice
pig
dilut
block
buffer
kpl
seracar
follow
h
incub
scoat
plate
rt
singl
well
measur
hyperimmun
serum
mous
pig
util
posit
control
plate
wash
six
time
wash
buffer
kpl
seracar
incub
antibodi
detect
either
use
dilut
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
kpl
seracar
hrpconjug
goat
antipig
igg
kpl
seracar
block
buffer
kpl
seracar
h
incub
plate
wash
six
time
wash
buffer
kpl
seracar
fifti
microlit
abt
peroxidas
substrat
system
kpl
seracar
ad
well
rt
min
reaction
stop
ad
stop
solut
kpl
seracar
optic
densiti
od
read
wavelength
nm
emax
plu
micropl
reader
molecular
devic
crawley
uk
result
express
sampl
posit
ratio
sp
ratio
sp
ratio
repres
differ
od
valu
sampl
neg
control
divid
differ
od
valu
posit
neg
control
rectal
swab
resuspend
ml
pb
twofold
dilut
block
buffer
kpl
seracar
elisa
procedur
mention
modif
incub
suspens
supernat
h
c
follow
h
incub
secondari
antibodi
goat
antipig
iga
kpl
seracar
detect
fecal
iga
min
color
time
fecal
swab
challeng
pig
use
posit
control
rectal
swab
resuspend
ml
pb
supernat
use
rna
extract
procedur
rna
extract
perform
qiacub
ht
qiagen
chatsworth
ca
usa
use
qiaamp
cador
pathogen
mini
kit
qiagen
accord
manufactur
instruct
complementari
dna
cdna
synthesi
perform
revers
transcript
use
quantinova
probe
pcr
kit
qiagen
realtim
pcr
modifi
accord
previous
establish
method
use
specif
probe
pedvn
forward
primer
pedvn
revers
primer
realtim
pcr
condit
c
min
cycl
c
c
plasma
sampl
pig
incub
c
min
inactiv
complement
procedur
neutral
assay
perform
previous
publish
modif
briefli
plasma
sampl
dilut
dulbecco
modifi
eagl
medium
dmem
gibco
gaithersburg
md
usa
fifti
microlit
dilut
plasma
sampl
mix
equal
volum
incub
c
h
mixtur
ad
onto
vero
cell
grown
plate
confluenc
cell
incub
c
h
follow
two
wash
dmem
replac
fresh
postinocul
pi
medium
contain
dmem
gibco
gaithersburg
md
usa
supplement
tryptos
phosphat
broth
sigma
st
loui
mo
usa
yeast
extract
acumedia
lans
ca
usa
trypsin
gibco
gaithersburg
md
usa
cytopath
effect
cpe
observ
h
neutral
titer
plasma
calcul
reciproc
highest
dilut
without
cpe
result
igg
level
iga
level
bodi
weight
antibodi
titer
viral
shed
statist
compil
sa
statist
analysi
system
sa
institut
inc
cari
nc
usa
differ
group
compar
oneway
analysi
varianc
anova
signific
determin
pvalu
p
propag
sbac
deriv
cotransfect
ptriex
acmnpv
baculoviru
genom
cell
cell
lyse
analyz
western
blot
evalu
express
protein
posit
signal
protein
observ
size
around
kda
kda
respect
figur
neg
control
detect
signal
observ
lysat
cell
infect
wildtyp
acmnpv
viru
western
blot
analysi
pedv
protein
express
baculovirus
perform
probe
antihi
tag
antibodi
correspond
molecular
weight
protein
approxim
kda
kda
respect
cell
noninfect
cell
wildtyp
cell
infect
wild
type
acmnpv
sbac
cell
infect
sbac
cell
infect
gapdh
control
cellular
protein
equal
volum
load
visual
protein
display
surfac
sbac
electron
microscopi
em
investig
whether
protein
display
recombin
baculovirus
viral
particl
sbac
collect
purifi
cultur
supernat
probe
colloid
goldlabel
antibodi
examin
em
shown
figur
em
imag
reveal
regular
long
rodshap
virion
approxim
size
nm
clear
colloid
gold
particl
apex
sbac
figur
figur
wildtyp
baculoviru
wild
typebac
figur
virion
electron
micrograph
demonstr
posit
colloid
gold
signal
porcin
epidem
diarrhea
viru
pedv
fulllength
protein
surfac
recombin
sbac
b
wildtyp
bac
c
respect
sbac
pedv
display
baculoviru
viral
particl
pedv
display
baculoviru
viral
particl
wild
typebac
wildtyp
baculoviru
viral
particl
bar
repres
refer
nm
evalu
immunogen
sbac
pedv
sspecif
blood
igg
level
determin
day
preprim
week
postprim
week
postboost
mice
use
pedv
sbase
indirect
elisa
mean
sampletoposit
control
ratio
sp
ratio
analyz
shown
figur
day
week
postprim
mean
sp
ratio
system
igg
level
mice
sbac
group
respect
signific
differ
control
group
day
week
postboost
mean
sp
ratio
pedv
specif
igg
level
elev
sbac
group
respect
significantli
higher
control
group
statist
differ
system
pedv
specif
igg
level
observ
sbac
group
studi
system
antipedv
protein
igg
level
detect
pedv
proteinbas
elisa
x
axi
repres
day
post
vaccin
wherea
axi
show
sampletoposit
control
ratio
sp
ratio
optic
densiti
od
valu
elisa
sp
ratio
defin
ratio
differ
od
valu
sampl
neg
control
differ
od
valu
posit
neg
control
error
bar
repres
sd
valu
group
differ
time
point
solid
line
squar
icon
gray
line
round
icon
repres
climb
trend
igg
level
sbac
group
group
respect
igg
level
control
group
express
dot
line
triangl
icon
signific
differ
control
group
p
neutral
antibodi
pedvpt
serum
mice
analyz
shown
figur
detect
neutral
antibodi
group
day
preprim
week
postboost
neutral
antibodi
detect
either
control
group
averag
neutral
antibodi
titer
sbac
group
elev
reach
estim
system
immun
respons
pedv
plasma
igg
evalu
day
preprim
week
postprim
week
postboost
mean
sp
ratio
analyz
shown
figur
day
week
postprim
mean
sp
ratio
system
igg
level
pig
sbac
group
secularli
slowli
rise
respect
howev
igg
level
show
signific
differ
control
group
day
week
postboost
mean
sp
ratio
igg
level
pig
significantli
elev
sbac
group
respect
signific
differ
p
control
group
pedv
sspecif
mucos
iga
level
figur
although
statist
signific
fecal
iga
level
piglet
among
group
studi
iga
level
slightli
elev
group
day
week
postprim
mean
titer
neutral
antibodi
pedvpt
strain
differ
group
present
figur
studi
differ
level
neutral
antibodi
pedvpt
strain
detect
sbac
immun
group
neutral
antibodi
pedvpt
strain
detect
control
group
day
week
postboost
neutral
titer
sbac
group
respect
higher
control
group
interestingli
neutral
titer
pig
sbac
group
significantli
higher
control
group
signific
differ
neutral
antibodi
pedvpt
strain
note
control
group
studi
bodi
weight
piglet
monitor
everi
two
week
introduc
anim
facil
figur
although
pig
control
group
show
slightli
less
weight
gain
vaccin
period
compar
sbac
group
signific
differ
bodi
weight
observ
among
group
studi
figur
averag
bodi
weight
piglet
group
bodi
weight
piglet
measur
twoweek
interv
sinc
piglet
week
old
x
axi
time
line
indic
age
piglet
day
post
vaccin
day
post
challeng
piglet
vaccin
twice
week
old
week
old
label
white
arrow
piglet
challeng
week
old
label
black
solid
arrow
axi
averag
bodi
weight
five
piglet
group
error
bar
repres
sd
valu
group
differ
time
point
solid
line
squar
icon
gray
line
round
icon
repres
averag
bodi
weight
pig
sbac
group
group
respect
averag
bodi
weight
pig
control
group
express
dot
line
triangl
icon
pedvpt
challeng
clinic
sign
observ
group
oral
challeng
pig
figur
three
five
pig
control
group
present
mild
moder
diarrhea
score
day
post
challeng
dpc
dpc
pig
control
group
show
moder
sever
clinic
sign
studi
pig
control
group
day
wateri
diarrhea
score
recov
dpc
compar
sbac
immun
pig
show
decreas
overal
sever
diarrhea
delay
onset
diseas
shorten
cours
ill
compar
pig
control
group
immun
group
appear
clinic
sign
postpon
dpc
pig
show
milder
symptom
score
compar
control
group
studi
sbac
immun
group
importantli
four
five
pig
present
clinic
symptom
studi
except
one
pig
soft
fece
score
dpc
semifluid
fece
score
dpc
figur
accumul
stool
score
control
group
group
b
sbac
c
group
highli
virul
porcin
epidem
diarrhea
viru
pedvpt
challeng
clinic
sign
score
follow
rule
normal
stool
loos
consist
stool
semifluid
consist
stool
wateri
diarrhea
piglet
oral
challeng
day
post
vaccin
day
post
challeng
total
day
observ
period
taken
challeng
blank
squar
repres
score
loos
consist
stool
lightgray
squar
repres
score
semifluid
stool
darkgray
squar
repres
score
wateri
diarrhea
viral
shed
pedv
detect
pedv
nbase
realtim
rt
pcr
present
figur
pig
control
group
start
shed
pedv
stool
mean
valu
copi
number
log
copiesml
dpc
continu
increas
fluctuat
dpc
peak
viral
shed
log
copiesml
dpc
declin
dpc
dpc
amount
viral
shed
pig
control
group
detect
limit
immun
group
viru
start
detect
mean
copi
number
log
copiesml
dpc
last
day
peak
viral
shed
log
copiesml
dpc
importantli
pig
sbac
group
detect
viral
shed
dpc
except
pig
exhibit
intermitt
viral
shed
log
copiesml
dpc
log
copiesml
dpc
compar
control
group
amount
fecal
viral
shed
sbac
group
statist
significantli
lower
p
two
novel
recombin
baculovirus
display
fulllength
protein
sbac
domain
pedvpt
success
gener
studi
sbac
capabl
elicit
system
pedv
sspecif
igg
mice
piglet
signific
induct
neutral
antibodi
pedvpt
strain
could
detect
anim
immun
sbac
oral
challeng
sbac
vaccin
piglet
present
milder
clinic
symptom
significantli
lower
fecal
viral
shed
piglet
control
group
importantli
intramuscular
vaccin
sbac
elicit
superior
protect
pedv
intramuscular
vaccin
piglet
circul
north
america
asia
pedv
strain
exhibit
higher
pathogen
pedv
strain
respons
recent
outbreak
sbac
vaccin
base
base
fulllength
protein
taiwan
pedvpt
strain
might
good
candid
control
outbreak
highli
virul
pedv
util
baculoviru
display
system
express
antigen
vaccin
candid
one
brilliant
applic
baculoviru
approach
gener
achiev
cooper
protein
interest
baculovir
envelop
glycoprotein
anchor
protein
membran
bud
virion
differ
surfac
display
strategi
chang
signal
peptid
transmembran
domain
tm
cytoplasm
tail
domain
ctd
attempt
present
larg
complex
foreign
protein
well
simpl
peptid
avail
present
studi
use
tradit
chimer
display
strategi
consist
pedv
domain
fuse
tm
ctd
success
gener
importantli
sbac
display
fulllength
pedv
protein
without
fuse
tm
ctd
also
success
gener
confirm
knowledg
first
evid
show
fulllength
protein
coronaviru
could
success
display
surfac
baculoviru
util
pedv
origin
tm
ctd
studi
provid
ration
basi
use
baculoviru
display
fulllength
protein
coronaviru
approach
novel
tool
develop
vaccin
coronavirus
better
antigen
deliveri
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
current
two
condit
licens
ped
vaccin
alphavirusbas
vaccin
harrisvacccin
inc
ame
iowa
usa
inactiv
vaccin
zoeti
inc
parsippani
new
jersey
usa
target
highli
virul
pedv
avail
unit
state
howev
avail
countri
former
vaccin
pedv
rna
vaccin
previou
result
show
applic
vaccin
could
reduc
mortal
piglet
second
one
use
kill
pedv
virus
low
viral
yield
titer
limit
broad
applic
vaccin
recent
sever
studi
use
fulllength
ectodomain
trimer
protein
differ
truncat
protein
deriv
differ
pedv
combin
commerci
adjuv
subunit
vaccin
regimen
despit
subunit
vaccin
abl
induc
robust
system
igg
neutral
antibodi
pedv
fail
complet
prevent
clinic
symptom
fecal
viral
shed
present
studi
piglet
vaccin
sbac
elicit
higher
neutral
antibodi
titer
good
protect
efficaci
vaccin
pig
despit
promot
robust
level
system
pedv
sspecif
igg
pig
mice
remark
differ
protect
efficaci
sbac
vaccin
suggest
import
integr
protein
induc
neutral
antibodi
protect
immun
protein
pedv
import
viral
protein
establish
infect
elicit
neutral
antibodi
host
domain
majorli
respons
virushost
recognit
interact
particip
membran
fusion
viru
intern
sever
pedv
neutral
epitop
domain
report
domain
domain
b
equival
epitop
coe
hand
epitop
cover
cterminu
region
junction
nterminu
region
also
verifi
effect
neutral
epitop
pedv
howev
also
neutral
epitop
pedv
identifi
ctd
protein
epitop
ctermin
site
sever
linear
epitop
ntermin
site
region
near
epitop
result
superior
immuneprotect
sbac
vaccin
indic
baculoviru
display
protein
compris
region
crucial
gener
protect
immun
pedv
welldemonstr
baculoviru
serv
strong
b
cell
adjuv
protein
antigen
viral
particl
baculoviru
abl
evok
robust
innat
immun
respons
regul
cytokin
interleukin
tumor
necrosi
factor
alpha
may
take
place
block
viral
infect
studi
demonstr
sbac
immun
without
adjuv
could
evok
pedv
sspecif
system
immun
respons
eas
clinic
symptom
decreas
viral
shed
certain
extent
although
sbac
immun
elicit
robust
system
immun
almost
complet
protect
piglet
challeng
still
one
five
piglet
exhibit
mild
symptom
delay
low
level
viral
shed
concern
detect
low
level
fecal
iga
sbac
immun
piglet
new
regimen
induc
mucos
immun
critic
pedv
vaccin
develop
instanc
introduc
specif
adjuv
ltb
ctb
cholera
toxin
b
along
baculoviru
display
antigen
propel
mucos
cellular
immun
experiment
design
intramuscularli
inject
vaccin
util
adjuv
capabl
either
boost
immun
elev
common
mucos
immun
consid
